deltatrials
Completed PHASE1 INTERVENTIONAL 7-arm NCT01273155

Belinostat for Solid Tumors and Lymphomas in Patients With Varying Degrees of Hepatic Dysfunction

Phase I Pharmacokinetic Study of Belinostat for Solid Tumors and Lymphomas in Patients With Varying Degrees of Hepatic Dysfunction

Sponsor: National Cancer Institute (NCI)

Conditions Lymphomas Neoplasms
Interventions Belinostat
Updated 17 times since 2017 Last updated: Mar 4, 2019 Started: Jan 10, 2011 Primary completion: Oct 25, 2017 Completion: Oct 25, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Lymphomas and Neoplasms and is currently completed. National Cancer Institute (NCI) leads this study, which shows 17 recorded versions since 2011 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~May 2017 · 3 months · monthly snapshot~May 2017 – ~Sep 2017 · 4 months · monthly snapshot~Sep 2017 – ~Nov 2017 · 2 months · monthly snapshot~Nov 2017 – ~Jan 2018 · 2 months · monthly snapshot~Jan 2018 – ~May 2018 · 4 months · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Aug 2018 · 31 days · monthly snapshot~Aug 2018 – ~Dec 2018 · 4 months · monthly snapshot~Dec 2018 – ~Jan 2019 · 31 days · monthly snapshot~Jan 2019 – ~Apr 2019 · 3 months · monthly snapshot~Apr 2019 – ~Jan 2021 · 21 months · monthly snapshot~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

17 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE1

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE1

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1

  5. Apr 2019 — Jan 2021 [monthly]

    Completed PHASE1

▶ Show 12 earlier versions

  1. Jan 2019 — Apr 2019 [monthly]

    Completed PHASE1

  2. Dec 2018 — Jan 2019 [monthly]

    Completed PHASE1

  3. Aug 2018 — Dec 2018 [monthly]

    Completed PHASE1

  4. Jul 2018 — Aug 2018 [monthly]

    Completed PHASE1

  5. Jun 2018 — Jul 2018 [monthly]

    Completed PHASE1

  6. May 2018 — Jun 2018 [monthly]

    Completed PHASE1

  7. Jan 2018 — May 2018 [monthly]

    Completed PHASE1

  8. Nov 2017 — Jan 2018 [monthly]

    Completed PHASE1

    Status: Recruiting → Completed

  9. Sep 2017 — Nov 2017 [monthly]

    Recruiting PHASE1

  10. May 2017 — Sep 2017 [monthly]

    Recruiting PHASE1

  11. Feb 2017 — May 2017 [monthly]

    Recruiting PHASE1

  12. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE1

    First recorded

Jan 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Cancer Institute (NCI)
Data source: National Institutes of Health Clinical Center (CC)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations